Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04656548 · ClinicalTrials.gov registry record
A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line
A clinical trial, sponsored by Access Vascular.
- Completed
- Registry status
- 121
- Enrollment target
NCT04656548 is a clinical trial that has completed, run by Access Vascular. The registered enrollment target is 121 participants.
The verdict
NCT04656548 has completed, sponsored by Access Vascular.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
Study Summary
This is a retrospective, matched pair comparative post market review of 4Fr Single Lumen PICC lines. The subjects will be matched by the timeframe of when the HydroPICCs were inserted.
Interventions
- DEVICE HydroPICC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2021-04-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04656548
The ClinicalTrials.gov registry entry for NCT04656548 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Access Vascular, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HydroPICC is the first listed.
NCT04656548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04656548 about?
NCT04656548 is a clinical study titled "A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line". This is a retrospective, matched pair comparative post market review of 4Fr Single Lumen PICC lines. The subjects will be matched by the timeframe of when the HydroPICCs were inserted.
What is the current status of trial NCT04656548?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2020-11-13. Estimated completion is 2021-04-23.
What interventions are being tested in trial NCT04656548?
The interventions under investigation include: HydroPICC (DEVICE).
Who is sponsoring clinical trial NCT04656548?
This trial is sponsored by Access Vascular, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.